Advancing therapeutic strategies for Epstein-Barr virus-associated malignancies through lytic reactivation

作者：Tan, Haiqi; Gong, Yibing; Liu, Yi; Long, Jingyi; Luo, Qingshuang; Faleti, Oluwasijibomi Damola; Lyu, Xiaoming^*

来源：Biomedicine and Pharmacotherapy, 2023, 164: 114916.

DOI：10.1016/j.biopha.2023.114916

• EBV
• Lytic reactivation
• Carcinogenesis
• Therapies

Epstein-Barr virus (EBV) is a widespread human herpes virus associated with lymphomas and epithelial cell cancers. It establishes two separate infection phases, latent and lytic, in the host. Upon infection of a new host cell, the virus activates several pathways, to induce the expression of lytic EBV antigens and the production of infectious virus particles. Although the carcinogenic role of latent EBV infection has been established, recent research suggests that lytic reactivation also plays a significant role in carcinogenesis. In this review, we sum-marize the mechanism of EBV reactivation and recent findings about the role of viral lytic antigens in tumor formation. In addition, we discuss the treatment of EBV-associated tumors with lytic activators and the targets that may be therapeutically effective in the future.

• 单位
  南方医科大学